Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clotting and Bleeding Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03956836
What this trial is testing

Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Coagulation DisorderCarcinomatosis
Hospitales Universitarios Virgen del Rocío 46
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Testing effectiveness (Phase 2)Study completedNCT00487656
What this trial is testing

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

Who this might be right for
SepsisDisseminated Intravascular Coagulation
Artisan Pharma, Inc. 750
Post-approval studies (Phase 4)WithdrawnNCT00168051
What this trial is testing

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableEnded earlyNCT01481012
What this trial is testing

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

Who this might be right for
Congestive Heart Failure
Icahn School of Medicine at Mount Sinai 94
Not applicableLooking for participantsNCT05629130
What this trial is testing

Embolization in Hereditary Coagulopathies

Who this might be right for
HemophiliaEmbolizationHemarthrosis+3 more
University of Sao Paulo General Hospital 30
Post-approval studies (Phase 4)UnknownNCT05522465
What this trial is testing

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Who this might be right for
Immune ThrombocytopeniaGlucocorticoidsChild, Only
Fujian Medical University Union Hospital 608
Not applicableApproved For MarketingNCT05770219
What this trial is testing

Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda
Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Not applicableLooking for participantsNCT04728841
What this trial is testing

Gene Therapy for Chinese Hemophilia A

Who this might be right for
Hemophilia AGene Therapy
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Not Yet RecruitingNCT07315373
What this trial is testing

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Not applicableStudy completedNCT00091494
What this trial is testing

Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+2 more
University of Michigan 1,000
Not applicableEnrolling By InvitationNCT06816953
What this trial is testing

Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis

Who this might be right for
Hemophilia A
Chulalongkorn University 19
Large-scale testing (Phase 3)UnknownNCT04915482
What this trial is testing

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune Thrombocytopenia (ITP)AutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 94
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Early research (Phase 1)Looking for participantsNCT05709288
What this trial is testing

Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 9
Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00381550
What this trial is testing

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more
National Cancer Institute (NCI) 35
Next Page